{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,17]],"date-time":"2026-05-17T03:58:12Z","timestamp":1778990292378,"version":"3.51.4"},"reference-count":85,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2012,4,1]],"date-time":"2012-04-01T00:00:00Z","timestamp":1333238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Trends in Endocrinology & Metabolism"],"published-print":{"date-parts":[[2012,4]]},"DOI":"10.1016\/j.tem.2011.10.002","type":"journal-article","created":{"date-parts":[[2011,12,7]],"date-time":"2011-12-07T13:08:18Z","timestamp":1323263298000},"page":"163-168","source":"Crossref","is-referenced-by-count":19,"title":["Heart drugs that affect bone"],"prefix":"10.1016","volume":"23","author":[{"given":"Jennifer S.","family":"Walsh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Newman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Eastell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.tem.2011.10.002_bib0005","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1016\/j.cell.2009.06.051","article-title":"A serotonin-dependent mechanism explains the leptin regulation of bone mass, appetite, and energy expenditure","volume":"138","author":"Yadav","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.tem.2011.10.002_bib0010","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00223-004-0024-1","article-title":"From molds and macrophages to mevalonate: a decade of progress in understanding the molecular mode of action of bisphosphonates","volume":"75","author":"Rogers","year":"2004","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.tem.2011.10.002_bib0015","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1749-6632.2009.05230.x","article-title":"Nitric oxide and bone","volume":"1192","author":"Wimalawansa","year":"2010","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.tem.2011.10.002_bib0020","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.286.5446.1946","article-title":"Stimulation of bone formation in vitro and in rodents by statins","volume":"286","author":"Mundy","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.tem.2011.10.002_bib0025","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1006\/bbrc.2000.4232","article-title":"Simvastatin promotes osteoblast differentiation and mineralization in MC3T3-E1 cells","volume":"280","author":"Maeda","year":"2001","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tem.2011.10.002_bib0030","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1006\/bbrc.2000.2697","article-title":"Compactin and simvastatin, but not pravastatin, induce bone morphogenetic protein-2 in human osteosarcoma cells","volume":"271","author":"Sugiyama","year":"2000","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.tem.2011.10.002_bib0035","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1359\/jbmr.2000.15.4.650","article-title":"Compactin suppresses bone resorption by inhibiting the fusion of prefusion osteoclasts and disrupting the actin ring in osteoclasts","volume":"15","author":"Woo","year":"2000","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.tem.2011.10.002_bib0040","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1359\/jbmr.2003.18.1.88","article-title":"The ability of statins to inhibit bone resorption is directly related to their inhibitory effect on HMG-CoA reductase activity","volume":"18","author":"Staal","year":"2003","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.tem.2011.10.002_bib0045","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00223-001-2027-5","article-title":"Statin given perorally to adult rats increases cancellous bone mass and compressive strength","volume":"69","author":"Oxlund","year":"2001","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.tem.2011.10.002_bib0050","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1093\/ije\/dyl147","article-title":"Reanalysis of two studies with contrasting results on the association between statin use and fracture risk: the General Practice Research Database","volume":"35","author":"de Vries","year":"2006","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.tem.2011.10.002_bib0055","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1001\/jama.283.24.3211","article-title":"HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients","volume":"283","author":"Wang","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/j.tem.2011.10.002_bib0060","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1359\/JBMR.040607","article-title":"HMG-CoA reductase inhibitors and the risk of vertebral fracture","volume":"19","author":"Schoofs","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.tem.2011.10.002_bib0065","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/S0140-6736(00)02400-4","article-title":"Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women","volume":"355","author":"Chan","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.tem.2011.10.002_bib0070","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s00198-003-1568-z","article-title":"Hip fracture risk in statin users \u2013 a population-based Danish case-control study","volume":"15","author":"Rejnmark","year":"2004","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.tem.2011.10.002_bib0075","doi-asserted-by":"crossref","first-page":"97","DOI":"10.7326\/0003-4819-139-2-200307150-00009","article-title":"Statin use, clinical fracture, and bone density in postmenopausal women: results from the Women's Health Initiative Observational Study","volume":"139","author":"LaCroix","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.tem.2011.10.002_bib0080","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.bone.2005.04.012","article-title":"Comparison of the effects of pravastatin and atorvastatin on fracture incidence in the PROVE IT-TIMI 22 trial \u2013 secondary analysis of a randomized controlled trial","volume":"37","author":"Reid","year":"2005","journal-title":"Bone"},{"key":"10.1016\/j.tem.2011.10.002_bib0085","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0140-6736(00)04042-3","article-title":"Effect of pravastatin on frequency of fracture in the LIPID study: secondary analysis of a randomised controlled trial. Long-term Intervention with Pravastatin in Ischaemic Disease","volume":"357","author":"Reid","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.tem.2011.10.002_bib0090","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.bone.2009.12.023","article-title":"Effects of statins vs. non-statin lipid-lowering therapy on bone formation and bone mineral density biomarkers in patients with hyperlipidemia","volume":"46","author":"Chuengsamarn","year":"2010","journal-title":"Bone"},{"key":"10.1016\/j.tem.2011.10.002_bib0095","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1359\/jbmr.040209","article-title":"Effects of simvastatin on bone turnover and BMD: a 1-year randomized controlled trial in postmenopausal osteopenic women","volume":"19","author":"Rejnmark","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.tem.2011.10.002_bib0100","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00198-004-1598-1","article-title":"Age-dependent effects of atorvastatin on biochemical bone turnover markers: a randomized controlled trial in postmenopausal women","volume":"15","author":"Berthold","year":"2004","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.tem.2011.10.002_bib0105","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1016\/j.bone.2007.02.019","article-title":"Effects of statins on bone mineral density: a meta-analysis of clinical studies","volume":"40","author":"Uzzan","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.tem.2011.10.002_bib0110","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00198-006-0079-0","article-title":"Transdermal application of lovastatin to rats causes profound increases in bone formation and plasma concentrations","volume":"17","author":"Gutierrez","year":"2006","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.tem.2011.10.002_bib0115","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0169-6009(08)80105-5","article-title":"Characterization of beta-adrenergic receptors on rat and human osteoblast-like cells and demonstration that beta-receptor agonists can stimulate bone resorption in organ culture","volume":"23","author":"Moore","year":"1993","journal-title":"Bone Miner."},{"key":"10.1016\/j.tem.2011.10.002_bib0120","first-page":"105","article-title":"Effects of beta-blockers on fracture risk","volume":"8","author":"Reid","year":"2008","journal-title":"J. Musculoskelet. Neuronal. Interact."},{"key":"10.1016\/j.tem.2011.10.002_bib0125","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1124\/jpet.106.105437","article-title":"Dose effects of propranolol on cancellous and cortical bone in ovariectomized adult rats","volume":"318","author":"Bonnet","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.tem.2011.10.002_bib0130","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1359\/jbmr.0301214","article-title":"Beta-adrenergic blockers reduce the risk of fracture partly by increasing bone mineral density: Geelong Osteoporosis Study","volume":"19","author":"Pasco","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.tem.2011.10.002_bib0135","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.bone.2010.10.170","article-title":"Association between beta-blocker use and fracture risk: the Dubbo Osteoporosis Epidemiology Study","volume":"48","author":"Yang","year":"2011","journal-title":"Bone"},{"key":"10.1016\/j.tem.2011.10.002_bib0140","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s00223-006-0213-1","article-title":"Use of beta-blockers and the risk of hip\/femur fracture in the United Kingdom and The Netherlands","volume":"80","author":"de Vries","year":"2007","journal-title":"Calcif. Tissue Int."},{"key":"10.1016\/j.tem.2011.10.002_bib0145","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1097\/01.hjh.0000203845.26690.cb","article-title":"Treatment with beta-blockers, ACE inhibitors, and calcium-channel blockers is associated with a reduced fracture risk: a nationwide case-control study","volume":"24","author":"Rejnmark","year":"2006","journal-title":"J. Hypertens."},{"key":"10.1016\/j.tem.2011.10.002_bib0150","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1111\/j.1532-5415.2005.53178_7.x","article-title":"Beta-blocker use, bone mineral density, and fracture risk in older women: results from the Epidemiologie de l\u2019Osteoporose prospective study","volume":"53","author":"Levasseur","year":"2005","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.tem.2011.10.002_bib0155","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1002\/jbmr.356","article-title":"The risk of fractures in older adults using anti-hypertensive medications","volume":"26","author":"Solomon","year":"2011","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.tem.2011.10.002_bib0160","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1359\/JBMR.041202","article-title":"Beta-blocker use, BMD, and fractures in the study of osteoporotic fractures","volume":"20","author":"Reid","year":"2005","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.tem.2011.10.002_bib0165","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1016\/j.bone.2007.01.006","article-title":"Protective effect of beta blockers in postmenopausal women: influence on fractures, bone density, micro and macroarchitecture","volume":"40","author":"Bonnet","year":"2007","journal-title":"Bone"},{"key":"10.1016\/j.tem.2011.10.002_bib0170","doi-asserted-by":"crossref","first-page":"5212","DOI":"10.1210\/jc.2005-0573","article-title":"Effects of a beta-blocker on bone turnover in normal postmenopausal women: a randomized controlled trial","volume":"90","author":"Reid","year":"2005","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2011.10.002_bib0175","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0140-6736(89)92205-8","article-title":"Long-term use of thiazide diuretics and risk of hip fracture","volume":"1","author":"Ray","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/j.tem.2011.10.002_bib0180","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/jama.1991.03460030076032","article-title":"Thiazide diuretics and the risk of hip fracture. Results from the Framingham Study","volume":"265","author":"Felson","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.tem.2011.10.002_bib0185","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1056\/NEJM199002013220502","article-title":"Thiazide diuretic agents and the incidence of hip fracture","volume":"322","author":"LaCroix","year":"1990","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2011.10.002_bib0190","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/oxfordjournals.aje.a008920","article-title":"Risk factors for osteoporotic fractures in elderly men","volume":"144","author":"Nguyen","year":"1996","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.tem.2011.10.002_bib0195","doi-asserted-by":"crossref","first-page":"476","DOI":"10.7326\/0003-4819-139-6-200309160-00010","article-title":"Thiazide diuretics and the risk for hip fracture","volume":"139","author":"Schoofs","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.tem.2011.10.002_bib0200","doi-asserted-by":"crossref","first-page":"666","DOI":"10.7326\/0003-4819-118-9-199305010-00002","article-title":"Effects of thiazide diuretic therapy on bone mass, fractures, and falls. The Study of Osteoporotic Fractures Research Group","volume":"118","author":"Cauley","year":"1993","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.tem.2011.10.002_bib0205","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-115-1-1","article-title":"Diuretic drug use and the risk for hip fracture","volume":"115","author":"Heidrich","year":"1991","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.tem.2011.10.002_bib0210","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1056\/NEJM198308113090605","article-title":"Thiazide effect on the mineral content of bone","volume":"309","author":"Wasnich","year":"1983","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.tem.2011.10.002_bib0215","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/oxfordjournals.aje.a116954","article-title":"Thiazides and bone mineral density in elderly men and women","volume":"139","author":"Morton","year":"1994","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.tem.2011.10.002_bib0220","doi-asserted-by":"crossref","first-page":"187","DOI":"10.7326\/0003-4819-124-2-199601150-00001","article-title":"Axial bone mass in older women. Study of Osteoporotic Fractures Research Group","volume":"124","author":"Orwoll","year":"1996","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.tem.2011.10.002_bib0225","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1046\/j.1365-2796.2001.00850.x","article-title":"Increased bone mineral density in a population-based group of 70-year-old women on thiazide diuretics, independent of parathyroid hormone levels","volume":"250","author":"Sigurdsson","year":"2001","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.tem.2011.10.002_bib0230","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.maturitas.2010.01.007","article-title":"Bone turnover markers and bone mineral density in hypertensive postmenopausal women on treatment","volume":"65","author":"Olmos","year":"2010","journal-title":"Maturitas"},{"key":"10.1016\/j.tem.2011.10.002_bib0235","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0002-9378(85)80035-1","article-title":"Thiazide diuretics and bone mineral content in postmenopausal women","volume":"152","author":"Adland-Davenport","year":"1985","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.tem.2011.10.002_bib0240","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/jbmr.5650080604","article-title":"Determinants of bone mineral density and risk factors for osteoporosis in healthy elderly women","volume":"8","author":"Ooms","year":"1993","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.tem.2011.10.002_bib0245","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00198-006-0259-y","article-title":"The effect of treatment with a thiazide diuretic for 4 years on bone density in normal postmenopausal women","volume":"18","author":"Bolland","year":"2007","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.tem.2011.10.002_bib0250","doi-asserted-by":"crossref","first-page":"516","DOI":"10.7326\/0003-4819-133-7-200010030-00010","article-title":"Low-dose hydrochlorothiazide and preservation of bone mineral density in older adults. A randomized, double-blind, placebo-controlled trial","volume":"133","author":"LaCroix","year":"2000","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.tem.2011.10.002_bib0255","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s00198-008-0612-4","article-title":"Effects of three years of low-dose thiazides on mineral metabolism in healthy elderly persons","volume":"19","author":"Ott","year":"2008","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.tem.2011.10.002_bib0260","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1210\/jc.2008-1662","article-title":"Treatment with potassium bicarbonate lowers calcium excretion and bone resorption in older men and women","volume":"94","author":"Dawson-Hughes","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2011.10.002_bib0265","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/jbmr.5650100708","article-title":"Nitric oxide: a cytokine-induced regulator of bone resorption","volume":"10","author":"Ralston","year":"1995","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.tem.2011.10.002_bib0270","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1359\/jbmr.1997.12.11.1797","article-title":"Cytokine-induced nitric oxide inhibits bone resorption by inducing apoptosis of osteoclast progenitors and suppressing osteoclast activity","volume":"12","author":"van\u2019t Hof","year":"1997","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.tem.2011.10.002_bib0275","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0002-9440(10)63963-6","article-title":"Endothelial nitric oxide synthase gene-deficient mice demonstrate marked retardation in postnatal bone formation, reduced bone volume, and defects in osteoblast maturation and activity","volume":"158","author":"Aguirre","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.tem.2011.10.002_bib0280","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1210\/en.142.2.760","article-title":"Defective bone formation and anabolic response to exogenous estrogen in mice with targeted disruption of endothelial nitric oxide synthase","volume":"142","author":"Armour","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.tem.2011.10.002_bib0285","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/8756-3282(96)00005-1","article-title":"Nitric oxide donor alleviates ovariectomy-induced bone loss","volume":"18","author":"Wimalawansa","year":"1996","journal-title":"Bone"},{"key":"10.1016\/j.tem.2011.10.002_bib0290","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S8756-3282(97)00125-7","article-title":"Prevention of corticosteroid-induced bone loss with nitric oxide donor nitroglycerin in male rats","volume":"21","author":"Wimalawansa","year":"1997","journal-title":"Bone"},{"key":"10.1016\/j.tem.2011.10.002_bib0295","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1359\/jbmr.060804","article-title":"Decreased fracture risk in users of organic nitrates: a nationwide case-control study","volume":"21","author":"Rejnmark","year":"2006","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.tem.2011.10.002_bib0300","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1210\/jc.2009-2342","article-title":"Use of organic nitrates and the risk of hip fracture: a population-based case-control study","volume":"95","author":"Pouwels","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2011.10.002_bib0305","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00198-008-0727-7","article-title":"Nitrate use and changes in bone mineral density: the Canadian Multicentre Osteoporosis Study","volume":"20","author":"Jamal","year":"2009","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.tem.2011.10.002_bib0310","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1359\/jbmr.1998.13.11.1755","article-title":"Intermittent use of nitrates increases bone mineral density: the study of osteoporotic fractures","volume":"13","author":"Jamal","year":"1998","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.tem.2011.10.002_bib0315","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1359\/jbmr.2000.15.6.1119","article-title":"Frequency-dependent effect of nitric oxide donor nitroglycerin on bone","volume":"15","author":"Wimalawansa","year":"2000","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.tem.2011.10.002_bib0320","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1359\/JBMR.040716","article-title":"Isosorbide mononitrate increases bone formation and decreases bone resorption in postmenopausal women: a randomized trial","volume":"19","author":"Jamal","year":"2004","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.tem.2011.10.002_bib0325","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1210\/jc.2008-2225","article-title":"Transdermal nitroglycerin therapy may not prevent early postmenopausal bone loss","volume":"94","author":"Wimalawansa","year":"2009","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2011.10.002_bib0330","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1001\/jama.2011.176","article-title":"Effect of nitroglycerin ointment on bone density and strength in postmenopausal women: a randomized trial","volume":"305","author":"Jamal","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.tem.2011.10.002_bib0335","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-2796.2004.01434.x","article-title":"Effects of long-term treatment with loop diuretics on bone mineral density, calcitropic hormones and bone turnover","volume":"257","author":"Rejnmark","year":"2005","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.tem.2011.10.002_bib0340","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1359\/JBMR.051003","article-title":"Loop diuretics increase bone turnover and decrease BMD in osteopenic postmenopausal women: results from a randomized controlled study with bumetanide","volume":"21","author":"Rejnmark","year":"2006","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.tem.2011.10.002_bib0345","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1111\/j.1365-2796.2005.01585.x","article-title":"Fracture risk in patients treated with loop diuretics","volume":"259","author":"Rejnmark","year":"2006","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.tem.2011.10.002_bib0350","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/PL00004174","article-title":"Predictors of fractures in elderly women","volume":"11","author":"Tromp","year":"2000","journal-title":"Osteoporos. Int."},{"key":"10.1016\/j.tem.2011.10.002_bib0355","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1001\/archinternmed.2008.526","article-title":"Loop diuretic use and fracture in postmenopausal women: findings from the Women's Health Initiative","volume":"169","author":"Carbone","year":"2009","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.tem.2011.10.002_bib0360","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/archinte.168.7.735","article-title":"Loop diuretic use and increased rates of hip bone loss in older men: the Osteoporotic Fractures in Men Study","volume":"168","author":"Lim","year":"2008","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.tem.2011.10.002_bib0365","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1152\/physrev.1989.69.3.990","article-title":"Osteocalcin and matrix Gla protein: vitamin K-dependent proteins in bone","volume":"69","author":"Hauschka","year":"1989","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.tem.2011.10.002_bib0370","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1359\/jbmr.2000.15.5.872","article-title":"Diet- or warfarin-induced vitamin K insufficiency elevates circulating undercarboxylated osteocalcin without altering skeletal status in growing female rats","volume":"15","author":"Haffa","year":"2000","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.tem.2011.10.002_bib0375","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0049-3848(02)00035-X","article-title":"Long-term treatment with sodium warfarin results in decreased femoral bone strength and cancellous bone volume in rats","volume":"105","author":"Simon","year":"2002","journal-title":"Thromb. Res."},{"key":"10.1016\/j.tem.2011.10.002_bib0380","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1677\/JOE-07-0119","article-title":"Warfarin-induced impairment of cortical bone material quality and compensatory adaptation of cortical bone structure to mechanical stimuli","volume":"194","author":"Sugiyama","year":"2007","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.tem.2011.10.002_bib0385","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1359\/jbmr.070208","article-title":"Vitamin K deficiency from long-term warfarin anticoagulation does not alter skeletal status in male rhesus monkeys","volume":"22","author":"Binkley","year":"2007","journal-title":"J. Bone Miner. Res."},{"key":"10.1016\/j.tem.2011.10.002_bib0390","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1210\/jcem-64-1-59","article-title":"Impaired carboxylation of osteocalcin in warfarin-treated patients","volume":"64","author":"Menon","year":"1987","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.tem.2011.10.002_bib0395","doi-asserted-by":"crossref","first-page":"829","DOI":"10.7326\/0003-4819-128-10-199805150-00006","article-title":"Warfarin use and risk for osteoporosis in elderly women. Study of Osteoporotic Fractures Research Group","volume":"128","author":"Jamal","year":"1998","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.tem.2011.10.002_bib0400","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1532-5415.2008.01786.x","article-title":"Single-point assessment of warfarin use and risk of osteoporosis in elderly men","volume":"56","author":"Woo","year":"2008","journal-title":"J. Am. Geriatr. Soc."},{"key":"10.1016\/j.tem.2011.10.002_bib0405","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/archinte.166.2.241","article-title":"Risk of osteoporotic fracture in elderly patients taking warfarin: results from the National Registry of Atrial Fibrillation 2","volume":"166","author":"Gage","year":"2006","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.tem.2011.10.002_bib0410","first-page":"635","article-title":"Decreased axial and peripheral bone density in patients taking long-term warfarin","volume":"88","author":"Philip","year":"1995","journal-title":"QJM"},{"key":"10.1016\/j.tem.2011.10.002_bib0415","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1159\/000256650","article-title":"Long-term oral anticoagulation therapy and the risk of hip fracture in patients with previous hemispheric infarction and nonrheumatic atrial fibrillation","volume":"29","author":"Sato","year":"2010","journal-title":"Cerebrovasc. Dis."},{"key":"10.1016\/j.tem.2011.10.002_bib0420","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/0002-9343(93)90121-5","article-title":"Vitamin K and maintenance of skeletal integrity in adults","volume":"94","author":"Rosen","year":"1993","journal-title":"Am. J. Med."},{"key":"10.1016\/j.tem.2011.10.002_bib0425","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00198-006-0250-7","article-title":"Fracture risk in patients treated with amiodarone or digoxin for cardiac arrhythmias: a nation-wide case\u2013control study","volume":"18","author":"Rejnmark","year":"2007","journal-title":"Osteoporos. Int."}],"container-title":["Trends in Endocrinology & Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276011001652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043276011001652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T09:48:10Z","timestamp":1561024090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043276011001652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,4]]},"references-count":85,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2012,4]]}},"alternative-id":["S1043276011001652"],"URL":"https:\/\/doi.org\/10.1016\/j.tem.2011.10.002","relation":{},"ISSN":["1043-2760"],"issn-type":[{"value":"1043-2760","type":"print"}],"subject":[],"published":{"date-parts":[[2012,4]]}}}